Goldman Sachs’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Goldman Sachs’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$205K	Hold	69,409	–	–	﹤0.01%	6191
2026 Q1	$69.4K	Hold	69,409	–	–	﹤0.01%	6260
2025 Q4	$23.6K	Hold	69,409	–	–	﹤0.01%	6333
2025 Q3	$23.9K	Hold	69,409	–	–	﹤0.01%	6229
2025 Q2	$15.3K	Hold	69,409	–	–	﹤0.01%	5998
2025 Q1	$16.5K	Hold	69,409	–	–	﹤0.01%	5953
2024 Q4	$14.6K	Hold	69,409	–	–	﹤0.01%	5923
2024 Q3	$13.2K	Hold	69,409	–	–	﹤0.01%	5694
2024 Q2	$14.1K	Hold	69,409	–	–	﹤0.01%	5529
2024 Q1	$17.4K	Hold	69,409	–	–	﹤0.01%	5404
2023 Q4	$13.4K	Hold	69,409	–	–	﹤0.01%	5468
2023 Q3	$17.5K	Hold	69,409	–	–	﹤0.01%	5368
2023 Q2	$27.4K	Hold	69,409	–	–	﹤0.01%	5516
2023 Q1	$19.4K	Hold	69,409	–	–	﹤0.01%	5672
2022 Q4	$17.4K	Hold	69,409	–	–	﹤0.01%	5712
2022 Q3	$31K	Hold	69,409	–	–	﹤0.01%	5856
2022 Q2	$33K	Hold	69,409	–	–	﹤0.01%	6105
2022 Q1	$42K	Buy	+69,409	New	+$37.9K	﹤0.01%	6298

Other funds holding DRTSW

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Goldman Sachs's DRTSW Position: Q2 2026 in Review

Goldman Sachs held its Alpha Tau Medical Warrant (DRTSW) position steady in Q2 2026 at 69,409 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #6191.

Goldman Sachs first reported a position in DRTSW in Q1 2022 and has held it in 18 quarters since. 21 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

Goldman Sachs held 69,409 shares of Alpha Tau Medical Warrant worth $205K as of Q2 2026.
Goldman Sachs left its Alpha Tau Medical Warrant share count unchanged in Q2 2026.
Alpha Tau Medical Warrant made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6191 holding.
Goldman Sachs first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 18 quarters since.
21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.